Form D — NextPoint Therapeutics, Inc.
0001959209-26-000002 · filed Jul 30, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $48,729,165
- Reported amount sold
- $33,728,772
- Minimum investment
- $0
- Investors
- 15
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- NextPoint Therapeutics, Inc.
- CIK
- 1959209
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 238 MAIN STREET
CAMBRIDGE, MA 02142 - Phone
- 508-204-1115
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Detlev Biniszkiewicz · DirectorCambridge, MA Find on LinkedIn ↗
-
Ivan Cheung · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Axel Hoos · DirectorCambridge, MA Find on LinkedIn ↗
-
R. Jacob Vogelstein · DirectorCambridge, MA Find on LinkedIn ↗
-
Brian Shuster · DirectorCambridge, MA Find on LinkedIn ↗
-
Paulina Hill · DirectorCambridge, MA Find on LinkedIn ↗
-
Rakhshita Dhar · DirectorCambridge, MA Find on LinkedIn ↗
-
Jeffrey Lacey · Executive OfficerCambridge, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗